Tech Company Financing Transactions
Neuronex Funding Round
Neuronex secured a $1.5 million Series A funding round on 10/8/2010. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/8/2010
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9001 Aerial Center Parkway 110
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Neuronex is a development stage pharmaceutical company focused on drugs that treat Central Nervous System (CNS) diseases and disorders. The company aims to combine clinical expertise with a thorough knowledge of the drug development process in a nimble, entrepreneurial environment, to achieve rapid success in obtaining approvals for our products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Moise Khayrallah
Chief Financial Officer
Karen Adams
Co-Founder
Gary Bream
VP - Operations
Stephen Butts
Browse more venture capital transactions:
Prev: 10/8/2010: Picard venture capital transaction
Next: 10/8/2010: Halfpenny Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs